Abstract: In an aspect of the disclosure, a method, a computer-readable medium, and an apparatus are provided. The apparatus may be a user equipment (UE) or component thereof. The apparatus may be configured to transmit to a base station a first request to transmit data in a buffer. The apparatus may be further configured to transmit to the base station a second request to transmit the data in the buffer in absence of a grant in response to the first transmit request. The apparatus may be further configured to remain awake for at least a portion of a scheduled discontinuous reception (DRX) sleep state following the transmission of the second request.

Abstract: A supported metallocene catalyst includes a carrier and a metallocene component. The carrier includes an inorganic oxide particle and an alkyl aluminoxane material. The inorganic oxide particle includes at least one inorganic oxide compound selected from the group consisting of an oxide of Group 3A and an oxide of Group 4A. The alkyl aluminoxane material includes an alkyl aluminoxane compound and an alkyl aluminum compound that is present in amount ranging from greater than 0.01 wt % to less than 14 wt % base on 100 wt % of the alkyl aluminoxane material. The metallocene component is supported on the carrier, and includes one of a metallocene compound containing a metal from Group 3B, a metallocene compound containing a metal from Group 4B, and a combination thereof. A method for preparing the supported metallocene catalyst and a method for preparing polyolefin using the supported metallocene catalyst are also disclosed.

Abstract: A cloud-device synergy-based battery management system is provided in this application, which includes a vehicle and a cloud BMS. The vehicle includes a vehicle BMS. The vehicle BMS is configured to: measure a battery parameter of the vehicle, and send first battery parameter data obtained through measurement to the cloud BMS. The cloud BMS is configured to: train second battery parameter data, and send a first training result obtained through training to the vehicle BMS, where the second battery parameter data includes the first battery parameter data and historical battery parameter data. The system implements vehicle battery management through cooperation of the vehicle BMS and the cloud BMS. Further, a vehicle, and a battery management method are also provided in this application.

Abstract: An endoscope, including: a handle, a sheath tube, an endoscopic cannula, and a tensioning mechanism. The sheath tube includes a first axial guide hole and a first joint pin disposed in the first axial guide hole. The handle includes a second axial guide hole and a second joint pin disposed in the second axial guide hole. The first joint pin matches and is directly connected to the second joint pin. The sheath tube matches and connects to the handle. The handle includes a cavity and the tensioning mechanism is disposed in the cavity. The endoscopic cannula includes a flexible part extending out of the sheath tube and a rigid part fixed in the sheath tube. The flexible part includes a steering wire. The first joint pin is connected to the steering wire. The tensioning mechanism is connected to the second joint pin.

Abstract: A sheath cap includes a housing collar and a cylinder which is coaxially fixed on the inner surface of one end of the housing collar. The cylinder is internally provided with instrument channel straight holes and a water spray channel straight hole which are parallel to the axial direction of the cylinder. The sheath cap is provided with an oblique hole, which is in communication with the water spray channel straight hole and is configured to spray water to the lateral front side of the sheath cap.

Abstract: A doctor health monitoring system based on a medical apparatus includes the medical apparatus (1), a detection system (2), a control system (3) and an artificial intelligence system (14). The detection system (2) is configured to detect health indicators of doctors and send the detected health indicators to the control system (3). The control system (3) and the artificial intelligence system (14) are integrated within the medical apparatus (1). The control system (3) is configured to send the detected health indicators from the detection system to a display device (11) for display. The artificial intelligence system (14) is configured to analyze the detected health indicators in the cloud server (12) for obtaining a diagnostic accuracy of the detected health indicators and a physical health status of the doctors. The detection system (2) capable of detecting the health indicators of the doctors is connected with the medical apparatus (1).

Abstract: The disclosure relates to a pharmaceutical composition including daphnetin, a method for improving aortic endothelial cell function, and use of daphnetin in preparation of a medicine for improving aortic endothelial cell function. The daphnetin is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The daphnetin is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid.

Abstract: The present disclosure discloses a novel compound, 3,4-dihydroxyphenethyl 3-hydroxybutanoate, a method for preparing the same and use of the same, and in particular, a compound of formula I, use of the compound of formula I, optically pure isomers of the compound, a mixture of enantiomers in any ratio, or pharmaceutically acceptable salts thereof in preparing health food and drug for relieving brain fatigue, improving learning and memory abilities, and ameliorating mania mood related to brain fatigue.

Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.

Abstract: The disclosure relates to a pharmaceutical composition including daphnetin, a method for improving aortic endothelial cell function, and use of daphnetin in preparation of a medicine for improving aortic endothelial cell function. The daphnetin is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The daphnetin is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid.

Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.

Abstract: A device for visibly puncturing an animal tissue or organ including a balloon, a canula, a needle tube, an image acquisition device, and a fluid injection tube. The balloon includes two ends. The canula includes a first axial through hole. The needle tube includes a second axial through hole and is disposed in the first axial through hole. The image acquisition device is disposed in the second axial through hole. The canula is a tubular structure slidable along the axial direction of the needle tube. The balloon is attached to the canula along the axial direction of the canula; the two ends of the balloon are disposed on the outer wall of the canula. The second axial through hole includes a fluid channel disposed between the outer wall of the needle tube and the inner wall of the balloon.

Abstract: A device for visible puncture includes a balloon, a canula, a needle tube, an image acquisition device, and a fluid injection tube. The balloon includes a first end including a first hole, and a second end including a second hole. The canula includes a first axial through hole. The needle tube includes a second axial through hole and is disposed in the first axial through hole. The image acquisition device is disposed in the second axial through hole. The balloon is axially disposed on the canula. The first end of the balloon is disposed on the outer wall of the front end of the needle tube, and the second end of the balloon is disposed on the outer wall of the front end of the canula. The second axial through hole includes a fluid channel disposed between the outer wall of the needle tube and the canula.

Abstract: The present disclosure relates to use of daphnetin in preparation of composition for improving cognitive ability, particularly discloses use of daphnetin in preparation of a composition for preventing or treating disorders caused by increased ?-amyloid level, and use of daphnetin as an inhibitor of ?-amyloid. The present disclosure also relates to use of daphnetin in preparation of a composition for preventing or treating cognitive disorders, which are the Alzheimer's disease and Parkinson's disease.

Abstract: An endoscopic cannula, including: a handle; a sheath; a core rod disposed in the sheath and capable of sliding along an axial direction of the sheath. The core rod includes a first channel, a second channel, and a third channel. The handle includes a first joint configured to guide a lead wire into the first channel, a second joint configured to guide water into the second channel, and a third joint configured to guide an endoscope into the third channel. The sheath includes a first end and a second end, and the second end is disposed in the handle.

Abstract: A self-locking angle adjustment mechanism for an endoscope includes: an endoscope angle adjustment steel wire (5), a rotation handle (2), an endoscope handle (3) and a self-locking rotation device, wherein: an outer conical surface is provided at an external surface of the rotation shaft (7), a conical cylinder is sleeved onto the outer conical surface; a spring (14), which can drive the rotation shaft to move towards a direction of the conical cylinder or drive the conical cylinder to move towards a direction of the rotation shaft, and can force the inner conical surface to closely fit with the outer conical surface for self-locking, is located along an axial direction of the rotation shaft or conical cylinder. Through the present invention, the flexible sheath is locked stepless at any position, meeting free positioning requirement of endoscope during surgeries, reducing labor strength during surgeries, avoiding patient injuries caused by misoperations.

Abstract: An endoscope, including: a handle, a sheath tube, an endoscopic cannula, and a tensioning mechanism. The sheath tube includes a first axial guide hole and a first joint pin disposed in the first axial guide hole. The handle includes a second axial guide hole and a second joint pin disposed in the second axial guide hole. The first joint pin matches and is directly connected to the second joint pin. The sheath tube matches and connects to the handle. The handle includes a cavity and the tensioning mechanism is disposed in the cavity. The endoscopic cannula includes a flexible part extending out of the sheath tube and a rigid part fixed in the sheath tube. The flexible part includes a steering wire. The first joint pin is connected to the steering wire. The tensioning mechanism is connected to the second joint pin.

Abstract: The present invention relates to a multidirectional turning endoscope, which includes an insertion portion (2), an endoscope handle (4) and a bending driving portion (3); wherein: the bending driving portion includes a left-right driving rod, an up-down driving rod, a rotation shaft, a left turning wheel (17), a right turning wheel (18) and a spring (19); the rotation shaft includes a left half shaft (15) and a right half shaft (16); the external surface of the left half shaft and the external surface of the right half shaft respectively have a left outer conical face and a right outer conical face, a left conical cylinder and a right conical cylinder (20) are respectively sleeved to the left outer conical face and a right outer conical face; a spring (19) is located at an axial direction of the left half shaft and the right half shaft.

Abstract: The present invention discloses a single-camera system for measuring a vehicle distance and measurement method thereof. The single-camera system for measuring the vehicle distance comprises a variable-magnification single-camera module, an operational control module and an infrared emission module, wherein the operational control module is respectively connected with the variable-magnification single-camera module and the infrared emission module. The variable-magnification single-camera module is used for performing real-time video recording on a front scene, capturing the position information of a highlight speckle in a video image from a video and capturing the number of pixels occupied by the width/height of a vehicle license plate.

Abstract: The present invention discloses a ticket evading decision system with human face recognition and usage method thereof.